Related Experiment Video
Updated: Oct 9, 2026
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Characterization of graft-versus-host disease in SCID mice and prevention by physicochemical stressors
X Sheng-Tanner1, C McKerlie, D Spaner
1Division of Cancer Biology Research, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.
Background:
Graft versus host disease (GVHD) prevents potentially curative allogeneic stem cell transplantation from being offered to cancer patients who lack a suitably matched donor. New methods to prevent GVHD are required to allow successful transplants across major histocompatibility complex barriers.
Methods:
A model of GVHD in C.B-17 SCID mice was developed to allow the study of allo-activated donor T cells without confounding effects of host lymphocytes. The abilities of cyclosporin-A, anticytokine antibodies, and oxidative stress to prevent GVHD in this model was studied.
Results:
T cells from major histocompatibility-mismatched donor mice caused severe GVHD in sublethally irradiated SCID hosts that could be ameliorated by coadministration of donor bone marrow but not by cyclosporine-A or anticytokine antibodies. In contrast, three-log more T cells could be injected without clinical consequences if they had been pretreated with a combination of heat, ultraviolet light, and oxygenation. The effect was not the trivial result of donor T cell destruction because T cell reconstitution, although delayed, recovered to normal levels within 2 weeks. Protection from GVHD required oxygenation and was associated with normalization of the CD4/CD8 donor T cell ratio, recovery of host hematopoiesis, and decreased inflammatory cytokine production.
Conclusion:
Pretreatment of donor T cells with a combination of physicochemical stressors effectively prevents GVHD caused by major major histocompatibility disparities and may facilitate the safe transplantation of patients without HLA-identical donors.
Insights
Physicochemical stress pretreatment of donor T cells prevents graft versus host disease (GVHD), enabling allogeneic stem cell transplants for cancer patients lacking matched donors. This method facilitates safer transplants across major histocompatibility barriers.
Area of Science:
- Immunology
- Transplantation Biology
- Oncology
Background:
- Graft versus host disease (GVHD) limits allogeneic stem cell transplantation (SCT) for cancer patients lacking matched donors.
- Developing strategies to prevent GVHD is crucial for successful SCT across major histocompatibility complex (MHC) barriers.
Purpose of the Study:
- To investigate novel methods for preventing GVHD in allogeneic SCT.
- To assess the efficacy of physicochemical stressors in preventing GVHD.
Main Methods:
- A mouse model of GVHD in C.B-17 SCID mice was established to study donor T cells independently of host factors.
- The protective effects of cyclosporine-A, anticytokine antibodies, and oxidative stress were evaluated.
Main Results:
- Donor T cells induced severe GVHD, which was partially ameliorated by donor bone marrow but not by cyclosporine-A or anticytokine antibodies.
- Pretreatment of donor T cells with heat, UV light, and oxygenation prevented GVHD, allowing a higher cell dose without adverse effects.
- This protection was linked to oxygenation, normalization of the CD4/CD8 T cell ratio, host hematopoiesis recovery, and reduced inflammatory cytokines, without significant donor T cell destruction.
Conclusions:
- Physicochemical stress pretreatment of donor T cells effectively prevents GVHD in MHC-mismatched settings.
- This approach holds promise for facilitating SCT in patients lacking HLA-identical donors, expanding treatment options for cancer patients.
